Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction
The Journal of Physiology · 2025
DOI: 10.1113/jp288882 ↗At a glance
Übersichtsarbeit in The Journal of Physiology, 2025. Written by Katia S G Andrade and 6 co-authors. Institution: Heart Institute, University of South Florida, Tampa, FL, USA. Major MEDLINE topics: Aldehyde Dehydrogenase, Mitochondrial, Muscle, Skeletal, Mitochondria, Muscle, Mitochondria. Cited 1 times so far (Crossref); 93 references. Funded by: São Paulo Research Foundation (FAPESP).
Abstract (original language)
The maintenance of skeletal muscle relies on several cellular signalling pathways directly linked to mitochondrial function. Mitochondria support skeletal muscle bioenergetics and are known as a primary source of reactive oxygen species (ROS). Indeed, mitochondrial dysfunction‐induced excessive ROS accumulation leads to irreversible molecular damage caused by lipid peroxidation by product 4‐hydroxy‐trans‐2‐nonenal (4‐HNE), this is able to directly inactivate proteins and DNA, causing mitochondrial and cellular dysfunction. Aldehyde dehydrogenase 2 (ALDH2) is the primary enzyme responsible for counteracting this deleterious cycle by detoxifying aldehydes and converting them into less harmful molecules. In this context, ALDH2 is essential for functional skeletal muscle maintenance. In fact, studies published in the last decade show that ALDH2 overexpression downregulates atrophic genes; meanwhile, the lack of this protein is associated with muscle weakness and atrophy, demonstrating its relevance for maintaining muscle mass. In this context, interventions capable of increasing ALDH2 levels and/or activity are considered promising therapeutic strategies for mitigating oxidative damage, enhancing mitochondrial function, and preserving muscle integrity under adverse conditions. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Heart Institute, University of South Florida, Tampa, FL, USA.
- Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
- Institute of Biology, University of Campinas, Campinas, Sao Paulo, Brazil.
- Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
ORCID profiles: Zhigao Wang, Leonardo R Silveira
Funding
- São Paulo Research Foundation (FAPESP)
Cite
APA
Andrade, K. S. G., Liu, J., Guimarães, D. S. P. S. F., Ferreira, J. C. B., Wang, Z., Wang, D. Z., & Silveira, L. R. (2025). Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction. The Journal of Physiology. https://doi.org/10.1113/jp288882
Vancouver
Andrade KSG, Liu J, Guimarães DSPSF, Ferreira JCB, Wang Z, Wang DZ, et al. Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction. The Journal of Physiology. 2025. doi:10.1113/jp288882
BibTeX
@article{Andrade2025,
author = {Andrade, Katia S G and Liu, Jianming and Guimarães, Dimitrius Santiago P S F and Ferreira, Julio C B and Wang, Zhigao and Wang, Da-Zhi and Silveira, Leonardo R},
title = {Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp288882}
}
EUVIMED